Arkolith/Insider Trading/NRIX/Form 4

Ring Christine

Chief Legal OfficerNurix Therapeutics, Inc. (NRIX) · full profile →Form 4 · filed Jun 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$135K
Net Open-Market Flow
-$135K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 2, 2026Option exercise(M)3K$1.86$6K22K
Jun 2, 2026Sell(S)8K$16.60$135K14K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 2, 2026Option exercise(M)3K—$05K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001817199-26-000020) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML